The estimated Net Worth of Peter D Haytaian is at least $64.7 million dollars as of 10 March 2022. Mr. Haytaian owns over 17,703 units of Anthem Inc stock worth over $5,868,655 and over the last 10 years he sold ANTM stock worth over $53,755,514. In addition, he makes $5,076,970 as Executive Vice President et President of Commercial and Specialty Business Division at Anthem Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Haytaian ANTM stock SEC Form 4 insiders trading
Peter has made over 20 trades of the Anthem Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 17,703 units of ANTM stock worth $8,155,949 on 10 March 2022.
The largest trade he's ever made was selling 59,500 units of Anthem Inc stock on 22 March 2021 worth over $20,777,400. On average, Peter trades about 4,640 units every 68 days since 2014. As of 10 March 2022 he still owns at least 12,161 units of Anthem Inc stock.
You can see the complete history of Mr. Haytaian stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Peter Haytaian biography
Peter D. Haytaian is a Executive Vice President, President of Commercial and Specialty Business Division of the Company. From June 2014 until March 2018, Mr. Haytaian served as our Executive Vice President and President of the Government Business Division. Mr. Haytaian joined the Company in December 2012 with our acquisition of Amerigroup Corporation (“Amerigroup”) and served as President of our Medicaid business from August 2013 until June 2014. From 2005 to 2013, Mr. Haytaian held several leadership positions with Amerigroup, including serving as Chief Executive Officer of the North Region for Amerigroup’s Medicaid business from December 2012 until August 2013. Mr. Haytaian has extensive experience leading Medicare and Medicaid programs with Amerigroup and, prior thereto, with Oxford Health Plans, Inc. (health insurance).
What is the salary of Peter Haytaian?
As the Executive Vice President et President of Commercial and Specialty Business Division of Anthem Inc, the total compensation of Peter Haytaian at Anthem Inc is $5,076,970. There are 5 executives at Anthem Inc getting paid more, with Gail Boudreaux having the highest compensation of $15,473,100.
How old is Peter Haytaian?
Peter Haytaian is 50, he's been the Executive Vice President et President of Commercial and Specialty Business Division of Anthem Inc since 2018. There are 22 older and 1 younger executives at Anthem Inc. The oldest executive at Anthem Inc is Julie Hill, 73, who is the Independent Director.
Insiders trading at Anthem Inc
Over the last 10 years, insiders at Anthem Inc have traded over $153,319,533 worth of Anthem Inc stock and bought 10,600 units worth $3,007,039 . The most active insiders traders include Antonio F Neri, Ryan M. Schneider et Lewis Iii Hay. On average, Anthem Inc executives and independent directors trade stock every 21 days with the average trade being worth of $5,250,953. The most recent stock trade was executed by Charles Morgan Jr Kendrick on 9 June 2022, trading 6,328 units of ANTM stock currently worth $1,806,771.
What does Anthem Inc do?
Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.
What does Anthem Inc's logo look like?
Complete history of Mr. Haytaian stock trades at Anthem Inc
Anthem Inc executives and stock owners
Anthem Inc executives and other stock owners filed with the SEC include:
-
Gail Boudreaux,
President, Chief Executive Officer, Director -
Felicia Norwood,
Executive Vice President, President - Government Business Division -
Gloria McCarthy,
Executive Vice President, Chief Administrative Officer -
Gail Koziara Boudreaux,
Pres, CEO & Director -
John Gallina,
Chief Financial Officer, Executive Vice President -
Peter Haytaian,
Executive Vice President, President of Commercial and Specialty Business Division -
Thomas Zielinski,
Executive Vice President, General Counsel -
John Edward Gallina,
Exec. VP & CFO -
Gloria Marie McCarthy,
Exec. VP and Chief Admin. Officer -
Peter David Haytaian Esq.,
Exec. VP and Pres of Diversified Bus. & IngenioRx -
Felicia Farr Norwood,
Exec. VP & Pres of Gov. Bus. Division -
Elizabeth Tallett,
Independent Chairman of the Board -
Ramiro Peru,
Independent Director -
Julie Hill,
Independent Director -
Robert Dixon,
Independent Director -
Lewis Hay,
Independent Director -
R. Kerry Clark,
Independent Director -
Antonio Neri,
Independent Director -
Bahija Jallal,
Independent Director -
Ryan Schneider,
Independent Director -
Chris Rigg,
Vice President Investor Relations -
Ronald Penczek,
Senior Vice President, Chief Accounting Officer, Controller -
Prakash Patel,
Executive Vice President, President - Diversified Business Group -
Leah Stark,
Chief Human Resource Officer, Executive Vice President -
Stephen Vartan Tanal C.F.A.,
VP of Investor Relations -
Thomas H. Miller,
Sr. VP & Chief Information Officer -
Anil Bhatt,
Chief Technology Officer -
Ronald William Penczek,
Sr. VP, Controller & Chief Accounting Officer -
Scott Wayne Anglin,
SVP, Treasurer & Chief Investment Officer -
Joseph Swedish,
President & CEO -
William J Ryan,
Director -
George A Jr Schaefer,
Director -
Jose D. Tomas,
EVP & Chief HR Officer -
Jacquelyn H Wolf,
EVP & Chief HR Officer -
Craig E Samitt,
EVP & Chief Clinical Officer -
Wayne S De Veydt,
EVP & Chief Financial Officer -
Brian T Griffin,
EVP & President, CSBD -
Samuel R Md Nussbaum,
EVP & Chief Medical Officer -
Martin B Silverstein,
EVP & Chief Strategy Officer -
Kenneth R Goulet,
EVP, Commercial & Specialty -
Blair Williams Todt,
EVP and Chief Legal Officer -
Jeffrey D. Alter,
EVP, IngenioRx & Anthem Health -
Susan D. De Vore,
Director -
Charles Morgan Jr Kendrick,
EVP & President, Commercial